Generic Dalfampridine Tablet Marketed for Patients With MS – Drug for nerve pain boosts high for opioid abusers.

1968_Graphic Image_Standard_060115Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Generic Dalfampridine Tablet Marketed for Patients With MS – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889

Mylan has launched its 10 mg Dalfampridine Extended-Release Tablets, an authorized generic version of Acorda’s Ampyra (dalfampridine).1 Dalfampridine, which is being marketed to to treat adult patients with multiple sclerosis (MS), is indicated to improve patients’ ability to walk and increase speed.1-2

In a prepared statement, Mylan CEO Heather Bresch said the availability of the generic product is reflective of the company’s commitment to providing medication access to patients with MS. “Mylan offers 100 products in the area of CNS alone, including 20 of the top CNS products dispensed in the US,” she noted.1

The most common adverse effects associated with the use of Ampyra are urinary tract infection, insomnia, dizziness, headache, nausea, weakness, and back pain.2 Patients who use the drug are also at an increased risk for seizures, according to the FDA.3

CLIKC HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.